196 related articles for article (PubMed ID: 18332093)
1. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Olson JC; Erbey JR; Williams K; Forrest KY; Smithline Kinder L; Ellis D; Becker DJ
Diabetes Care; 2003 May; 26(5):1374-9. PubMed ID: 12716791
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.
Costacou T; Evans RW; Orchard TJ
Diabet Med; 2016 Nov; 33(11):1524-1527. PubMed ID: 27028131
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin genotype and renal function decline in type 1 diabetes.
Costacou T; Ferrell RE; Ellis D; Orchard TJ
Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Orchard TJ; Backlund JC; Costacou T; Cleary P; Lopes-Virella M; Levy AP; Lachin JM;
J Diabetes Complications; 2016; 30(8):1577-1584. PubMed ID: 27539884
[TBL] [Abstract][Full Text] [Related]
7. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T; Orchard TJ
J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
[TBL] [Abstract][Full Text] [Related]
8. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
[TBL] [Abstract][Full Text] [Related]
9. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
[TBL] [Abstract][Full Text] [Related]
10. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
11. The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.
Ju J; Tomaszewski EL; Orchard TJ; Evans RW; Feingold E; Costacou T
Acta Diabetol; 2020 Mar; 57(3):271-278. PubMed ID: 31529337
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin genotype and its role in diabetic cardiovascular disease.
Costacou T; Levy AP
J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes.
Syreeni A; Dahlström EH; Hägg-Holmberg S; Forsblom C; Eriksson MI; Harjutsalo V; Putaala J; Groop PH; Sandholm N; Thorn LM
Diabetes; 2022 Dec; 71(12):2728-2738. PubMed ID: 36409784
[TBL] [Abstract][Full Text] [Related]
14. Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck Study.
Pechlaner R; Kiechl S; Willeit P; Demetz E; Haun M; Weger S; Oberhollenzer F; Kronenberg F; Bonora E; Weiss G; Willeit J
J Am Heart Assoc; 2014 May; 3(3):e000732. PubMed ID: 24837587
[TBL] [Abstract][Full Text] [Related]
15. The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
Cheurfa N; Dubois-Laforgue D; Ferrarezi DA; Reis AF; Brenner GM; Bouché C; Le Feuvre C; Fumeron F; Timsit J; Marre M; Velho G
Diabetes; 2008 Apr; 57(4):1063-8. PubMed ID: 18192542
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes.
Eriksson MI; Syreeni A; Sandholm N; Dahlström EH; Gordin D; Tatlisumak T; Putaala J; Groop PH; Martola J; Thorn LM;
Acta Diabetol; 2023 Jun; 60(6):749-756. PubMed ID: 36856861
[TBL] [Abstract][Full Text] [Related]
17. Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study.
Warren RA; Bancks MP; Carew AS; Levy AP; Sapp J; Bahnson J; Lewis CE; Rimm EB; Espeland MA; Cahill LE
Cardiovasc Diabetol; 2024 Feb; 23(1):82. PubMed ID: 38402400
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.
Miller RG; Costacou T; Orchard TJ
Diab Vasc Dis Res; 2010 Jan; 7(1):47-55. PubMed ID: 20368232
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
[TBL] [Abstract][Full Text] [Related]
20. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women.
Olson JC; Edmundowicz D; Becker DJ; Kuller LH; Orchard TJ
Diabetes; 2000 Sep; 49(9):1571-8. PubMed ID: 10969842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
